Clinical Trial Update: Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating the safety and efficacy of insulin-like growth factor-1 in patients with myocardial infarction and heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction

Drugs mentioned

• Insulin-like Growth Factor-1 (insulin-like growth factor-1)

Snippet

Sponsor: University College Cork | Conditions: Heart Failure, Myocardial Infarction | Phase 1, Phase 2 | Status: COMPLETED